glp-1 in development Genetics: How Genes Affect Appetite, Semaglutide, and Tirzepatide Response Timeline of critical milestones in

Glucagon-like peptide-1 (GLP-1) is an incretin that increases insulin sensitivity and aids glucose metabolism

Marked expansion of exocrine and endocrine pancreas with incretin therapy in humans with increased exocrine pancreas dysplasia and the potential for glucagon-producing neuroendocrine tumors

Despite its brief half-life, its effects on growth hormone (GH) release can last longer, as it triggers a GH pulse that peaks approximately 30 minutes after administration and gradually declines over the next few hours

Aug 2019;78(3):438-448

R.PietrasR.Marquez-GarbanD

GLP-1 Coverage Strategies That Balance Cost and Talent The employers navigating this well arent choosing between covering GLP-1s and controlling costs